Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127766171 | 12776617 | 1 | I | 20160623 | 20160919 | 20160923 | 20160923 | EXP | US-PFIZER INC-2016441542 | PFIZER | 53.00 | YR | F | Y | 0.00000 | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127766171 | 12776617 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY, Q8H (EVERY EIGHT HOURS) | 21845 | 20 | MG | FILM-COATED TABLET | TID | ||||||
| 127766171 | 12776617 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.08 UG/KG, UNK | U | 929007 | 0 | .08 | UG/KG | INJECTION | |||||
| 127766171 | 12776617 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 127766171 | 12776617 | 4 | C | TORSEMIDE. | TORSEMIDE | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | ||||||||
| 127766171 | 12776617 | 5 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 127766171 | 12776617 | 6 | C | WARFARIN | WARFARIN | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 127766171 | 12776617 | 7 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 20 MEQ, 2X/DAY | 0 | 20 | MEQ | BID | |||||||
| 127766171 | 12776617 | 8 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0.125 MG, UNK | 0 | .125 | MG | ||||||||
| 127766171 | 12776617 | 9 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | 0 | 70 | MG | ||||||||
| 127766171 | 12776617 | 10 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 UG, DAILY | 0 | 50 | UG | ||||||||
| 127766171 | 12776617 | 11 | C | PEPCID | FAMOTIDINE | 1 | Oral | 20 MG, 2X/DAY, Q12H (EVERY 12 HOURS) | 0 | 20 | MG | BID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127766171 | 12776617 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127766171 | 12776617 | Cardiomegaly | |
| 127766171 | 12776617 | Chest discomfort | |
| 127766171 | 12776617 | Condition aggravated | |
| 127766171 | 12776617 | Disease progression | |
| 127766171 | 12776617 | Dyspnoea | |
| 127766171 | 12776617 | Gait disturbance | |
| 127766171 | 12776617 | Palpitations | |
| 127766171 | 12776617 | Sarcoidosis | |
| 127766171 | 12776617 | Sinus tachycardia | |
| 127766171 | 12776617 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127766171 | 12776617 | 2 | 20140613 | 0 |